Last reviewed · How we verify

Vitamin K2 — Competitive Intelligence Brief

Vitamin K2 (Vitamin K2) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin K analog. Area: Bone health, Cardiovascular.

marketed Vitamin K analog Gamma-glutamyl carboxylase cofactor Bone health, Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin K2 (Vitamin K2) — Ain Shams University. Vitamin K2 acts as a cofactor for gamma-carboxylation of bone and vascular proteins, enabling their biological activity in bone mineralization and cardiovascular health.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Vitamin K2 TARGET Vitamin K2 Ain Shams University marketed Vitamin K analog Gamma-glutamyl carboxylase cofactor
Vitamin K 2 Vitamin K 2 Catholic University of Salta marketed Vitamin K analog Gamma-glutamyl carboxylase cofactor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin K analog class)

  1. Ain Shams University · 1 drug in this class
  2. Catholic University of Salta · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin K2 — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-k2. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: